Decreased prevalence of lymphatic filariasis among subjects with type-1 diabetes.
Identifieur interne : 002908 ( PubMed/Checkpoint ); précédent : 002907; suivant : 002909Decreased prevalence of lymphatic filariasis among subjects with type-1 diabetes.
Auteurs : Vivekanandhan Aravindhan [Inde] ; Vishwanathan Mohan ; Jayagopi Surendar ; Maradana Muralidhara Rao ; Harish Ranjani ; V. Kumaraswami ; Thomas B. Nutman ; Subash BabuSource :
- The American journal of tropical medicine and hygiene [ 1476-1645 ] ; 2010.
Descripteurs français
- KwdFr :
- MESH :
English descriptors
- KwdEn :
- Adolescent, Adult, Antibodies, Helminth (blood), Child, Cross-Sectional Studies, Diabetes Mellitus, Type 1 (blood), Diabetes Mellitus, Type 1 (epidemiology), Elephantiasis, Filarial (blood), Elephantiasis, Filarial (complications), Female, Humans, Male, Middle Aged, Socioeconomic Factors, Young Adult.
- MESH :
- chemical , blood : Antibodies, Helminth.
- blood : Diabetes Mellitus, Type 1, Elephantiasis, Filarial.
- complications : Elephantiasis, Filarial.
- epidemiology : Diabetes Mellitus, Type 1.
- Adolescent, Adult, Child, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Socioeconomic Factors, Young Adult.
Abstract
Several animal studies have shown a protective effect of helminth infections against type-1 diabetes mellitus (T1DM). However, epidemiologic studies demonstrating this protective relationship with T1DM are largely lacking, although an inverse correlation between the prevalence of lymphatic filariasis (LF) and prevalence of allergies and autoimmunity has been shown. A cross-sectional study was undertaken in southern India to assess the baseline prevalence of seropositivity of LF among persons with T1DM (n = 200) and normal glucose tolerant (NGT) persons (n = 562). The prevalence of LF was 0% among persons with T1DM and 2.6% among NGT persons (P = 0.026). The percentage of persons who were positive for filarial antigen-specific IgG4 (but not antigen-specific IgG) was also significantly lower in persons with T1DM (2%) compared with NGT persons (28%) (P < 0.001). Thus, there appears to be a striking inverse relationship between the prevalence of LF and T1DM in southern India.
DOI: 10.4269/ajtmh.2010.10-0410
PubMed: 21118945
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:21118945Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Decreased prevalence of lymphatic filariasis among subjects with type-1 diabetes.</title><author><name sortKey="Aravindhan, Vivekanandhan" sort="Aravindhan, Vivekanandhan" uniqKey="Aravindhan V" first="Vivekanandhan" last="Aravindhan">Vivekanandhan Aravindhan</name><affiliation wicri:level="1"><nlm:affiliation>Laboratory of Molecular Immunology, Anna University-K. B. Chandrashekar Research Centre, Chennai, India. cvaravindhan@gmail.com</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Laboratory of Molecular Immunology, Anna University-K. B. Chandrashekar Research Centre, Chennai</wicri:regionArea><wicri:noRegion>Chennai</wicri:noRegion></affiliation></author><author><name sortKey="Mohan, Vishwanathan" sort="Mohan, Vishwanathan" uniqKey="Mohan V" first="Vishwanathan" last="Mohan">Vishwanathan Mohan</name></author><author><name sortKey="Surendar, Jayagopi" sort="Surendar, Jayagopi" uniqKey="Surendar J" first="Jayagopi" last="Surendar">Jayagopi Surendar</name></author><author><name sortKey="Rao, Maradana Muralidhara" sort="Rao, Maradana Muralidhara" uniqKey="Rao M" first="Maradana Muralidhara" last="Rao">Maradana Muralidhara Rao</name></author><author><name sortKey="Ranjani, Harish" sort="Ranjani, Harish" uniqKey="Ranjani H" first="Harish" last="Ranjani">Harish Ranjani</name></author><author><name sortKey="Kumaraswami, V" sort="Kumaraswami, V" uniqKey="Kumaraswami V" first="V" last="Kumaraswami">V. Kumaraswami</name></author><author><name sortKey="Nutman, Thomas B" sort="Nutman, Thomas B" uniqKey="Nutman T" first="Thomas B" last="Nutman">Thomas B. Nutman</name></author><author><name sortKey="Babu, Subash" sort="Babu, Subash" uniqKey="Babu S" first="Subash" last="Babu">Subash Babu</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2010">2010</date><idno type="RBID">pubmed:21118945</idno><idno type="pmid">21118945</idno><idno type="doi">10.4269/ajtmh.2010.10-0410</idno><idno type="wicri:Area/PubMed/Corpus">002832</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002832</idno><idno type="wicri:Area/PubMed/Curation">002832</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002832</idno><idno type="wicri:Area/PubMed/Checkpoint">002832</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002832</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Decreased prevalence of lymphatic filariasis among subjects with type-1 diabetes.</title><author><name sortKey="Aravindhan, Vivekanandhan" sort="Aravindhan, Vivekanandhan" uniqKey="Aravindhan V" first="Vivekanandhan" last="Aravindhan">Vivekanandhan Aravindhan</name><affiliation wicri:level="1"><nlm:affiliation>Laboratory of Molecular Immunology, Anna University-K. B. Chandrashekar Research Centre, Chennai, India. cvaravindhan@gmail.com</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Laboratory of Molecular Immunology, Anna University-K. B. Chandrashekar Research Centre, Chennai</wicri:regionArea><wicri:noRegion>Chennai</wicri:noRegion></affiliation></author><author><name sortKey="Mohan, Vishwanathan" sort="Mohan, Vishwanathan" uniqKey="Mohan V" first="Vishwanathan" last="Mohan">Vishwanathan Mohan</name></author><author><name sortKey="Surendar, Jayagopi" sort="Surendar, Jayagopi" uniqKey="Surendar J" first="Jayagopi" last="Surendar">Jayagopi Surendar</name></author><author><name sortKey="Rao, Maradana Muralidhara" sort="Rao, Maradana Muralidhara" uniqKey="Rao M" first="Maradana Muralidhara" last="Rao">Maradana Muralidhara Rao</name></author><author><name sortKey="Ranjani, Harish" sort="Ranjani, Harish" uniqKey="Ranjani H" first="Harish" last="Ranjani">Harish Ranjani</name></author><author><name sortKey="Kumaraswami, V" sort="Kumaraswami, V" uniqKey="Kumaraswami V" first="V" last="Kumaraswami">V. Kumaraswami</name></author><author><name sortKey="Nutman, Thomas B" sort="Nutman, Thomas B" uniqKey="Nutman T" first="Thomas B" last="Nutman">Thomas B. Nutman</name></author><author><name sortKey="Babu, Subash" sort="Babu, Subash" uniqKey="Babu S" first="Subash" last="Babu">Subash Babu</name></author></analytic><series><title level="j">The American journal of tropical medicine and hygiene</title><idno type="eISSN">1476-1645</idno><imprint><date when="2010" type="published">2010</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Antibodies, Helminth (blood)</term><term>Child</term><term>Cross-Sectional Studies</term><term>Diabetes Mellitus, Type 1 (blood)</term><term>Diabetes Mellitus, Type 1 (epidemiology)</term><term>Elephantiasis, Filarial (blood)</term><term>Elephantiasis, Filarial (complications)</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Socioeconomic Factors</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Anticorps antihelminthe (sang)</term><term>Diabète de type 1 (sang)</term><term>Diabète de type 1 (épidémiologie)</term><term>Enfant</term><term>Facteurs socioéconomiques</term><term>Femelle</term><term>Filariose lymphatique ()</term><term>Filariose lymphatique (sang)</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Études transversales</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Helminth</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Diabetes Mellitus, Type 1</term><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Diabetes Mellitus, Type 1</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antihelminthe</term><term>Diabète de type 1</term><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Diabète de type 1</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Child</term><term>Cross-Sectional Studies</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Socioeconomic Factors</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Enfant</term><term>Facteurs socioéconomiques</term><term>Femelle</term><term>Filariose lymphatique</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Études transversales</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Several animal studies have shown a protective effect of helminth infections against type-1 diabetes mellitus (T1DM). However, epidemiologic studies demonstrating this protective relationship with T1DM are largely lacking, although an inverse correlation between the prevalence of lymphatic filariasis (LF) and prevalence of allergies and autoimmunity has been shown. A cross-sectional study was undertaken in southern India to assess the baseline prevalence of seropositivity of LF among persons with T1DM (n = 200) and normal glucose tolerant (NGT) persons (n = 562). The prevalence of LF was 0% among persons with T1DM and 2.6% among NGT persons (P = 0.026). The percentage of persons who were positive for filarial antigen-specific IgG4 (but not antigen-specific IgG) was also significantly lower in persons with T1DM (2%) compared with NGT persons (28%) (P < 0.001). Thus, there appears to be a striking inverse relationship between the prevalence of LF and T1DM in southern India.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21118945</PMID><DateCreated><Year>2010</Year><Month>12</Month><Day>01</Day></DateCreated><DateCompleted><Year>2011</Year><Month>01</Month><Day>11</Day></DateCompleted><DateRevised><Year>2016</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1476-1645</ISSN><JournalIssue CitedMedium="Internet"><Volume>83</Volume><Issue>6</Issue><PubDate><Year>2010</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The American journal of tropical medicine and hygiene</Title><ISOAbbreviation>Am. J. Trop. Med. Hyg.</ISOAbbreviation></Journal><ArticleTitle>Decreased prevalence of lymphatic filariasis among subjects with type-1 diabetes.</ArticleTitle><Pagination><MedlinePgn>1336-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4269/ajtmh.2010.10-0410</ELocationID><Abstract><AbstractText>Several animal studies have shown a protective effect of helminth infections against type-1 diabetes mellitus (T1DM). However, epidemiologic studies demonstrating this protective relationship with T1DM are largely lacking, although an inverse correlation between the prevalence of lymphatic filariasis (LF) and prevalence of allergies and autoimmunity has been shown. A cross-sectional study was undertaken in southern India to assess the baseline prevalence of seropositivity of LF among persons with T1DM (n = 200) and normal glucose tolerant (NGT) persons (n = 562). The prevalence of LF was 0% among persons with T1DM and 2.6% among NGT persons (P = 0.026). The percentage of persons who were positive for filarial antigen-specific IgG4 (but not antigen-specific IgG) was also significantly lower in persons with T1DM (2%) compared with NGT persons (28%) (P < 0.001). Thus, there appears to be a striking inverse relationship between the prevalence of LF and T1DM in southern India.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aravindhan</LastName><ForeName>Vivekanandhan</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Immunology, Anna University-K. B. Chandrashekar Research Centre, Chennai, India. cvaravindhan@gmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohan</LastName><ForeName>Vishwanathan</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Surendar</LastName><ForeName>Jayagopi</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Maradana Muralidhara</ForeName><Initials>MM</Initials></Author><Author ValidYN="Y"><LastName>Ranjani</LastName><ForeName>Harish</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Kumaraswami</LastName><ForeName>V</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Nutman</LastName><ForeName>Thomas B</ForeName><Initials>TB</Initials></Author><Author ValidYN="Y"><LastName>Babu</LastName><ForeName>Subash</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Trop Med Hyg</MedlineTA><NlmUniqueID>0370507</NlmUniqueID><ISSNLinking>0002-9637</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000909">Antibodies, Helminth</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 2009 Dec;77(12):5347-58</RefSource><PMID Version="1">19752032</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Med (Berl). 2009 Dec;87(12):1173-8</RefSource><PMID Version="1">19693476</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biomed Biotechnol. 2010;2010:850541</RefSource><PMID Version="1">20069130</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2010 May 1;184(9):5375-82</RefSource><PMID Version="1">20357251</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2010;4(6):e707</RefSource><PMID Version="1">20559443</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetes Res Clin Pract. 2001 Jun;52(3):205-11</RefSource><PMID Version="1">11323090</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2001 Sep 7;286(5):1051-8</RefSource><PMID Version="1">11527407</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2004 May 15;172(10):6229-38</RefSource><PMID Version="1">15128811</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 1988 Nov;158(5):1034-7</RefSource><PMID Version="1">2460565</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 1993 Oct;92(4):1667-73</RefSource><PMID Version="1">8408619</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parasite Immunol. 1999 Apr;21(4):169-76</RefSource><PMID Version="1">10320614</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2006 Mar 1;176(5):3248-56</RefSource><PMID Version="1">16493086</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CMAJ. 2006 Jul 18;175(2):165-70</RefSource><PMID Version="1">16847277</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parasite Immunol. 2006 Oct;28(10):515-23</RefSource><PMID Version="1">16965287</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 2007 Jan;75(1):397-407</RefSource><PMID Version="1">17043101</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Endocrinol Metab. 2007 Jul;92(7):2403-7</RefSource><PMID Version="1">17616634</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pac Health Dialog. 2005 Mar;12(1):5</RefSource><PMID Version="1">18181455</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2008 May;13(5):737-42</RefSource><PMID Version="1">18346027</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Autoimmun Rev. 2008 Jul;7(7):550-7</RefSource><PMID Version="1">18625444</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Commun Dis. 2007 Sep;39(3):197-9</RefSource><PMID Version="1">18697586</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Assoc Physicians India. 2008 Jun;56:429-35</RefSource><PMID Version="1">18822622</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urban Health. 2008 Nov;85(6):938-51</RefSource><PMID Version="1">18931915</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Inflamm Bowel Dis. 2009 Jan;15(1):128-33</RefSource><PMID Version="1">18680198</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Immunol. 2008;100:125-49</RefSource><PMID Version="1">19111165</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunology. 2009 Jan;126(1):12-7</RefSource><PMID Version="1">19120494</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Endocr Res. 2008;33(1-2):1-15</RefSource><PMID Version="1">19156571</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parasitol Res. 2009 Jan;104(2):217-21</RefSource><PMID Version="1">19050918</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood Cells Mol Dis. 2009 Mar-Apr;42(2):105-7</RefSource><PMID Version="1">19027331</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dan Med Bull. 2009 Feb;56(1):1-39</RefSource><PMID Version="1">19232167</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2009 Jun 15;199(12):1827-37</RefSource><PMID Version="1">19456233</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunology. 2009 Aug;127(4):512-22</RefSource><PMID Version="1">19016910</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Aust Fam Physician. 2009 Sep;38(9):695-7</RefSource><PMID Version="1">19893797</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Autoimmun. 2009 Nov-Dec;33(3-4):197-207</RefSource><PMID Version="1">19819109</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000909" MajorTopicYN="N">Antibodies, Helminth</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC2990055</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21118945</ArticleId><ArticleId IdType="pii">83/6/1336</ArticleId><ArticleId IdType="doi">10.4269/ajtmh.2010.10-0410</ArticleId><ArticleId IdType="pmc">PMC2990055</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Inde</li></country></list><tree><noCountry><name sortKey="Babu, Subash" sort="Babu, Subash" uniqKey="Babu S" first="Subash" last="Babu">Subash Babu</name><name sortKey="Kumaraswami, V" sort="Kumaraswami, V" uniqKey="Kumaraswami V" first="V" last="Kumaraswami">V. Kumaraswami</name><name sortKey="Mohan, Vishwanathan" sort="Mohan, Vishwanathan" uniqKey="Mohan V" first="Vishwanathan" last="Mohan">Vishwanathan Mohan</name><name sortKey="Nutman, Thomas B" sort="Nutman, Thomas B" uniqKey="Nutman T" first="Thomas B" last="Nutman">Thomas B. Nutman</name><name sortKey="Ranjani, Harish" sort="Ranjani, Harish" uniqKey="Ranjani H" first="Harish" last="Ranjani">Harish Ranjani</name><name sortKey="Rao, Maradana Muralidhara" sort="Rao, Maradana Muralidhara" uniqKey="Rao M" first="Maradana Muralidhara" last="Rao">Maradana Muralidhara Rao</name><name sortKey="Surendar, Jayagopi" sort="Surendar, Jayagopi" uniqKey="Surendar J" first="Jayagopi" last="Surendar">Jayagopi Surendar</name></noCountry><country name="Inde"><noRegion><name sortKey="Aravindhan, Vivekanandhan" sort="Aravindhan, Vivekanandhan" uniqKey="Aravindhan V" first="Vivekanandhan" last="Aravindhan">Vivekanandhan Aravindhan</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002908 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002908 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:21118945
|texte= Decreased prevalence of lymphatic filariasis among subjects with type-1 diabetes.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:21118945" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |